Related scientific articles (all)

A phase I pharmacokinetics study of lapatinib and tamoxifen in metastatic breast cancer (EORTC 10053 Lapatam study).

Authors : Fumoleau P, Koch KM, Brain E, Lokiec F, Rezai K, Awada A, Hayward L, Werutsky G, Bogaerts J, Marréaud S, Cardoso F
Year : 2014
Journal : Breast
Volume : 23(5)
Pages : 663-9

Thrombo-embolic events in cancer patients with impaired renal function

Authors : Elalamy I, Canon JL, Bols A, Lybaert W, Duck L, Jochmans K, Bosquée L, Peeters M, Awada A, Clement P, Holbrechts S, Baurain JF, Mebis J, Nortier J
Year : 2014
Journal : J Strength Cond Res
Volume : 5(4)
Pages : 202

Strategies for the empirical management of infection in cancer patients with emphasis on the emergence of resistant gram-negative bacteria.

Authors : Klastersky J, Georgala A
Year : 2014
Journal : Crit Rev Oncol Hematol
Volume : 92(3)
Pages : 266-78

The Role of Age on Dose Limiting Toxicities (DLTs) in Phase I Dose-escalation Trials.

Authors : Schwandt A, Harris PJ, Hunsberger S, Deleporte A, Smith GL, Vulih D, Anderson BD, Ivy SP
Year : 2014
Journal : Clin Cancer Res
Volume : 20(18)
Pages : 4768-75

Foreword for the edition of Treatment Strategies

Authors : Awada A, Aftimos P
Year : 2014
Journal : Oncology
Volume : 4(1)
Pages : 9

Guidelines for time-to-event end-point definitions in trials for pancreatic cancer. Results of the DATECAN initiative (Definition for the Assessment of Time-to-event End-points in CANcer trials).

Authors : Bonnetain F, Bonsing B, Conroy T, Dousseau A, Glimelius B, Haustermans K, Lacaine F, Van Laethem JL, Aparicio T, Aust D, Bassi C, Berger V, Chamorey E, Chibaudel B, Dahan L, de Gramont A, Delpero JR, Dervenis C, Ducreux M, Gal J, Gerber E, Ghaneh P, Hammel P, Hendlisz A, Jooste V, Labianca R, Latouche A, Lutz M, Macarulla T, Malka D, Mauer M, Mitry E, Neoptolemos J, Pessaux P, Sauvanet A, Tabernero J, Taieb J, Van Tienhoven G, Gourgou-Bourgade S, Bellera C, Mathoulin-Pélissier S, Collette L
Year : 2014
Journal : Eur. J. Cancer
Volume : 50(17)
Pages : 2983-93

Treatment options for pregnant women with ovarian tumors.

Authors : Mancari R, Tomasi-Cont N, Sarno MA, Azim HA, Franchi D, Carinelli S, Biglia N, Colombo N, Peccatori FA
Year : 2014
Journal : Int J Gynecol Cancer
Volume : 24(6)
Pages : 967-72

Pioneering quality assessment in European cancer centers: a data analysis of the organization for European cancer institutes accreditation and designation program.

Authors : Saghatchian M, Thonon F, Boomsma F, Hummel H, Koot B, Harrison C, Rajan A, de Valeriola D, Otter R, Laranja Pontes J, Lombardo C, McGrath E, Ringborg U, Tursz T, Van Harten W
Year : 2014
Journal : J Oncol Pract
Volume : 10(5)
Pages : e342-9

Multicenter implementation of geriatric assessment in Belgian patients with cancer: A survey on treating physicians' general experiences and expectations.

Authors : Kenis C, Heeren P, Bron D, Decoster L, Moor R, Pepersack T, Langenaeken C, Rasschaert M, Jerusalem G, Van Rijswijk R, Lobelle JP, Flamaing J, Milisen K, Wildiers H
Year : 2014
Journal : J Geriatr Oncol
Volume : 5(4)
Pages : 431-8

Menopausal hormone therapy use in 17 European countries during the last decade.

Authors : Ameye L, Antoine C, Paesmans M, de Azambuja E, Rozenberg S
Year : 2014
Journal : Maturitas
Volume : 79(3)
Pages : 287-91

Lapatinib with trastuzumab for HER2-positive early breast cancer (NeoALTTO): survival outcomes of a randomised, open-label, multicentre, phase 3 trial and their association with pathological complete response.

Authors : de Azambuja E, Holmes AP, Piccart-Gebhart M, Holmes E, Di Cosimo S, Swaby RF, Untch M, Jackisch C, Lang I, Smith I, Boyle F, Xu B, Barrios CH, Perez EA, Azim HA, Kim SB, Kuemmel S, Huang CS, Vuylsteke P, Hsieh RK, Gorbunova V, Eniu A, Dreosti L, Tavartkiladze N, Gelber Rd, Eidtmann H, Baselga J
Year : 2014
Journal : Lancet Oncol
Volume : 15(10)
Pages : 1137-46

Everolimus plus exemestane as first-line therapy in HR(+), HER2 (-) advanced breast cancer in BOLERO-2.

Authors : Beck JT, Hortobagyi GN, Campone M, Lebrun F, Deleu I, Rugo HS, Pistilli B, Masuda N, Hart L, Melichar B, Dakhil S, Geberth M, Nunzi M, Heng DY, Brechenmacher T, El-Hashimy M, Douma S, Ringeisen F, Piccart-Gebhart M
Year : 2014
Journal : Breast Cancer Res. Treat.
Volume : 143(3)
Pages : 459-67

In times of crisis, go liquid!

Authors : Hendlisz A, Deleporte A, Vandeputte C
Year : 2014
Journal : Curr Opin Oncol
Volume : 26(4)
Pages : 440

Present and future breast cancer management--bench to bedside and back: a positioning paper of academia, regulatory authorities and pharmaceutical industry.

Authors : Bartsch R, Frings S, Marty M, Awada A, Berghoff AS, Conte P, Dickin S, Enzmann H, Gnant M, Hasmann M, Hendriks HR, Llombart A, Massacesi C, Von Minckwitz G, Penault-Llorca F, Scaltriti M, Yarden Y, Zwierzina H, Zielinski CC
Year : 2014
Journal : Ann Oncol
Volume : 25(4)
Pages : 773-80

Biology of breast cancer during pregnancy using genomic profiling.

Authors : Azim HA, Brohée S, Peccatori FA, Desmedt C, Loi S, Lambrechts D, Dell orto P, Majjaj S, Jose V, Rotmensz N, Ignatiadis M, Pruneri G, Piccart-Gebhart M, Viale G, Sotiriou C
Year : 2014
Journal : Endocr Relat Cancer
Volume : 21
Pages : 545-54

Supportive care is a constant state of changing: we need to adjust for it.

Authors : Klastersky J
Year : 2014
Journal : Curr Opin Oncol
Volume : 26(4)
Pages : 371

Reply to C. Fontanella et Al.

Authors : Azim HA, de Azambuja E, Agbor-Tarh D, Bradbury I
Year : 2014
Journal : J. Clin. Oncol.
Volume : 32(30)
Pages : 3459

TP53 mutation-correlated genes predict the risk of tumor relapse and identify MPS1 as a potential therapeutic kinase in TP53-mutated breast cancers.

Authors : Bottai G, Lehmann-Che J, Kéri G, Orfi L, Iwamoto T, Desmedt C, Bianchini G, Turner NC, de Thè H, André F, Sotiriou C, Hortobagyi GN, Di Leo A, Pusztai L, Santarpia L
Year : 2014
Journal : Mol oncol
Volume : 8(3)
Pages : 508-19

The 41st David A. Karnofsky Memorial Award Lecture: Academic research worldwide--quo vadis?

Authors : Piccart-Gebhart M
Year : 2014
Journal : J. Clin. Oncol.
Volume : 32(4)
Pages : 347-54

Information perception, wishes, and satisfaction in ambulatory cancer patients under active treatment: patient-reported outcomes with QLQ-INFO25.

Authors : Pinto AC, Ferreira-Santos F, Dal Lago L, de Azambuja E, Pimentel FL, Piccart-Gebhart M, Razavi D
Year : 2014
Journal : Ecancermedicalscience
Volume : 8(null)
Pages : 425